Phreesia vs pVerify
Two Patient Access & Intake vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Phreesia | pVerify | |
|---|---|---|
| Pricing model | Subscription (per user or PMPM) · Custom quote, roughly $250+ monthly plus transaction fees | Per-transaction / per-chart · Per-check API pricing, volume tiers |
| Speed to go live | Standard EHR-integrated intake rollout | API keys in days; portal is self-serve |
| Automation model | Software platform · Intake, payments, and messaging | Software platform · API and portal, no services layer |
| Built for | Small practices, Mid-size groups, Enterprise systems | Small practices, Mid-size groups, Billing companies |
| Security posture | SOC 2 Type II, HITRUST, PCI DSS, HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 21 yrs (est. 2005) | 20 yrs (est. 2006) |
| Financial backing | Public (NYSE: PHR) | Acquired by DoseSpot (2023) |
| Named customers | 2 named | None public |
| Published results | Specific numbers public | No public numbers |
| Documented integrations | 5 listed | 4 listed |
| Third-party validation | None found | KLAS / analyst cited |
Bottom line
- Pick Phreesia if you want a proven, heavily certified intake and payments layer tied to your EHR and can live with custom quotes and module fees.
- Pick pVerify if you want to embed accurate, specialty-aware eligibility checks into your own software or intake workflow through an API rather than buy a full RCM platform.
Phreesia
Public company powering patient intake and payments
- Founded
- 2005
- HQ
- Wilmington, DE
- Stage
- Public (NYSE: PHR)
- Raised
- n/a
What it does
- Digital patient intake, registration, and consent management
- Insurance eligibility verification and card capture
- Patient payments, payment plans, and receivables financing (AccessOne)
- Automated appointment scheduling, reminders, and waitlist fill
- Patient surveys, screenings, and post-visit engagement
- Handles roughly 1 in 6 US patient visits
Where it's strong
- Massive proven scale: over 180 million patient visits enabled in 2025 and deep bidirectional integrations with every major EHR.
- Now GAAP profitable ($480.6M revenue, $2.3M net income in fiscal 2026), so vendor viability risk is low.
- The AccessOne acquisition adds patient payment plans and financing, making it a fuller patient-payments platform.
What buyers should weigh
- Part of its business model is pharma-sponsored patient messaging, which some organizations find uncomfortable in an intake tool.
- Pricing runs higher than point solutions, and smaller practices may pay for breadth they will not use.
- It covers intake, access, and payments but is not a denials or back-end RCM solution.
Named customers
HeartPlace · Summit Orthopedics
Integrations
pVerify
REST APIs for real-time eligibility and benefits verification
- Founded
- 2006
- HQ
- Tustin, CA
- Stage
- Acquired by DoseSpot (2023)
- Raised
- n/a
What it does
- Real-time eligibility checks across 1,500+ payers
- Specialty-specific benefits parsing (vision, DME, therapy)
- Insurance discovery for unknown or inactive coverage
- Patient estimation and Medicare-specific checks (MBI lookup)
- Claim status and prior authorization support APIs
- Batch eligibility for appointment-day sweeps
Where it's strong
- Developer-first: well-documented APIs make it quick to embed eligibility into your own product.
- Specialty benefit parsing goes deeper than raw 270/271 responses from clearinghouses.
- Now part of PSG-backed DoseSpot, which adds financial stability and a bigger product family.
What buyers should weigh
- It solves front-end verification only; you still need separate tools for claims and denials.
- Named enterprise customer references are thin in public materials.
- Ongoing DoseSpot and Arrive Health consolidation (Interra Health) could shift roadmap priorities.
Integrations
Compare against the rest of Patient Access & Intake
Deciding between these two?
First Pass tracks Patient Access & Intake every week: funding, launches, and what changed since this page was written.